Day: October 16, 2020

LOUDON, Tenn., Oct. 16, 2020 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its first quarter fiscal 2021 financial results on Friday, November 6, 2020 before the market opens. Following the release, the company’s management will host a conference call to discuss the results at 8:30 a.m. Eastern Time on the same day.The call will be hosted by Malibu’s Chief Executive Officer, Jack Springer, and Chief Financial Officer, Wayne Wilson.Investors and analysts are invited to listen to the conference call by dialing (855) 433-0928 or (484) 756-4263 and using Conference ID #3295729. Alternatively, interested parties can listen to a live webcast of the conference call by logging on to the Investor Relations section of the Company’s website at http://investors.malibuboats.com/. A replay of the webcast...

SOUTH ORANGE, NJ, Oct. 16, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced the pricing of a registered direct offering of 833,333 shares of common stock at a price to the public of $6.00 per share.  The offering is expected to close on or about October 20, 2020, subject to the satisfaction of customary closing conditions.Total gross proceeds from the offering are expected to be approximately $5.0 million, before offering expenses.  Nephros intends to use the net proceeds of the offering for working capital and general corporate purposes. The shares are being offered pursuant to an effective...

MONTREAL, Oct. 16, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the appointment of Mr. Andrew Molson and Mr. Alain Trudeau as new independent members to its Board of Directors.“Both Andrew and Alain bring tremendous value to our Board. They are well-recognized and respected by their peers in the business community for their knowledge, expertise and vision,” said Ms. Dawn Svoronos, Chair of the Board, Theratechnologies Inc.“On behalf of the Board of Directors at Theratechnologies, it is my pleasure to welcome them. We look forward to the important contribution Andrew and Alain will make as Theratechnologies enters a new chapter in its history. Theratechnologies recently...

MONTRÉAL, 16 oct. 2020 (GLOBE NEWSWIRE) — Theratechnologies (Theratechnologies) (TSX: TH) (NASDAQ: THTX), une société biopharmaceutique commerciale axée sur le développement et la commercialisation de traitements innovateurs, a annoncé aujourd’hui la nomination de M. Andrew Molson et M. Alain Trudeau à titre de membres indépendants de son conseil d’administration.« Andrew et Alain apportent tous les deux de la valeur à notre conseil. Ils sont bien reconnus et respectés par leurs pairs de la communauté des affaires pour leurs connaissances, leur expertise et leur vision », a déclaré Mme Dawn Svoronos, présidente du conseil, Theratechnologies.« Au nom du conseil d’administration de Theratechnologies, je suis heureuse de leur souhaiter la bienvenue. Nous anticipons l’importante contribution qu’Andrew et Alain apporteront alors que...

If approved, inclisiran will be the first and only small interfering RNA (siRNA) in Europe for patients with hypercholesterolemia or mixed dyslipidemia1Cardiovascular disease (CVD) claims 3.9 million lives annually in Europe2, and 80% of high-risk patients do not reach guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets despite the widespread use of statins3–5Inclisiran provides effective and sustained reduction of LDL-C of up to 52%, with a safety profile similar to placebo, in patients with elevated LDL-C despite maximally tolerated lipid-lowering therapy6,7With only two doses a year administered by healthcare professionals, inclisiran is expected to support long-term adherence6,7Inclisiran is also under review by the U.S. FDA and other health authorities for the treatment of primary hyperlipidemia (including heterozygous...

MALVERN, Pa., Oct. 16, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced that Cantor Fitzgerald and Kristen Kluska will host a Management Fireside Chat Zoom Call on October 21 at 11 a.m. ET.Ocugen management, including Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Sanjay Subramanian, CFO, Dr. Mohamed Genead, Acting CMO and Chair of the Scientific Advisory Board, and Dr. Mark Pennesi, Scientific Advisory Board Member, will discuss Ocugen’s lead program, OCU400 (AAV-NR2E3), a modifier gene therapy indicated for retinal degeneration disorders. In addition, they will provide highlights from the clinical, histological, and functional outcomes as published in Nature Gene Therapy...

TORONTO, Oct. 16, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that recently acquired subsidiary, Transforming Systems, has developed an elective care module, SHREWD Elective, in cooperation with National Health Service (NHS) England. SHREWD Elective.The Elective module was developed in response to the need of NHS England to manage the growing pressure in planned care across the country. The proof of concept has been tested at Medway Foundation Trust and now proven and operational, has been purchased and is being implemented across the remaining 6 hospitals in the Kent and Medway region, with further discussions ongoing throughout the UK, presenting significant opportunity for future expansion.“Having had such great success with the SHREWD Resilience module in our Urgent...

– Provides for Cooperative Deployment of Charging Stations with Energy Storage to Support Growing Demand for Electric VehiclesLOS ANGELES, Oct. 16, 2020 (GLOBE NEWSWIRE) — SG Blocks, Inc. (NASDAQ: SGBX) a leading designer, innovator and fabricator of container-based structures, and Blink Charging Co. (NASDAQ: BLNK), a leading owner and operator of electric vehicle (EV) charging equipment and services, today jointly announced that they entered into an exclusive Master Development and Production Agreement pursuant to which Blink’s EV charging solutions will be deployed along with SG Blocks’ container-based modular building structures. The Agreement brings together two industry leaders and natural allies to deploy a rapid and cost-effective innovative EV charging solution. The EV charging containers will be designed to provide...

Data Further Support Potential of NT219 to Overcome Cancer Drug ResistanceTEL AVIV, Israel, Oct. 16, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, announced new data supporting the mechanism of action of NT219, a dual inhibitor, novel small molecule targeting IRS1/2 and STAT3 is being presented  in a  video recorded presentation at the Epigenetics and Metabolism AACR Special Virtual Conference by researchers at Tel-Aviv University. The data was generated as part of the Company’s collaboration with Professor Ido Wolf, Head of the Oncology Division, Tel Aviv Sourasky Medical Center.The new data demonstrates IRS2-amplified colorectal cancer (CRC) cells upregulate β-catenin expression, and treatment...

SHENZHEN, China, Oct. 16, 2020 (GLOBE NEWSWIRE) — Meten EdtechX Education Group Ltd. (NASDAQ: METX) (“Meten EdtechX” or the “Company”), a leading English language training (“ELT”) service provider in China, today announced a potential strategic partnership with Renaissance Learning Inc (“Renaissance”), a global leader in K-12 English assessment and reading education, and one of the world’s largest English and maths assessment education technology companies.Headquartered in London, Renaissance also has six offices in the United States and employs more than 1,100 people. It operates in 96 countries globally with more than 18 million users.In 2019, more than one third of schools in the United States and approximately half of schools in the United Kingdom were using Renaissance’s personalized levelled reading and practice solutions....